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Abstract  
The human EAG1 potassium channel belongs to the superfamily of KCNH voltage-gated potassium 
channels that have roles in cardiac repolarization and neuronal excitability. EAG1 is strongly 
inhibited by Ca2+-calmodulin (CaM) through a mechanism that is not understood. We determined the 
binding properties of CaM with each one of three previously identified binding sites (BDN, BDC1 
and BDC2), analyzed binding to protein stretches that include more than one site, and determined the 
effect of neighboring globular domains on the binding properties. The determination of the crystal 
structure of CaM bound to BDC2 shows the channel fragment interacting with only the C-lobe of 
calmodulin and adopting an unusual bent conformation. Based on this structure and on a functional 
and biochemical analysis of mutants, we propose a model for the mechanism of inhibition where the 
local conformational change induced by CaM binding at BDC2 is at the basis of channel modulation. 
 
Introduction 
Voltage-gated potassium channels of the KCNH family (EAG, ERG and ELK) are involved in 
important physiological processes like cardiac repolarization, neuronal excitability and cellular 
proliferation (Crociani et al., 2003; Pardo and Stuhmer, 2014; Sanguinetti and Tristani-Firouzi, 2006). 
These are tetrameric channels that contain large cytoplasmic regions which serve as interfaces for 
modulatory inputs such as phosphorylation, interaction with kinases, integrins and calmodulin 
(Cherubini et al., 2005; Morais-Cabral and Robertson, 2015; Schonherr et al., 2000; Sun et al., 2004; 
Wang et al., 2002; Warmke and Ganetzky, 1994). The cytoplasmic regions include a PAS domain on 
the N terminus and a domain with homology to cyclic nucleotide binding domains (CNB-homology 
domain, CNBhD) on the C terminus; it has been shown that the PAS domain and the CNB-homology 
domain interact with each other (Gustina and Trudeau, 2011; Haitin et al., 2013). 
K+ currents mediated by EAG1 channels are potently suppressed by intracellular Ca2+ with an IC50 of 
about 100 nM, an effect that is mediated by calmodulin with an IC50 of 6 nM for the Ca
2+-calmodulin 
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complex (Sahoo et al., 2010; Schonherr et al., 2000). Ca2+-CaM is here referred to as CaM to contrast 
with Ca2+-free apo-CaM. It has been proposed that binding of a single CaM complex is sufficient for 
inhibition of the tetrameric channel (Schonherr et al., 2000). Using a peptide array screen that spanned 
the whole EAG1 cytoplasmic regions, three CaM binding sequences were identified (Figure S1a): 
BDN, immediately after the PAS domain, and BDC1 and BDC2, just after the CNB-homology 
domain (Ziechner et al., 2006). Mutations that affect CaM binding to these sites result in channels that 
are nearly insensitive to CaM, supporting the functional importance of all sites in CaM-mediated 
inhibition. In addition, an in-cell FRET study showed that channels with disrupting mutations on 
BDN or BDC2 are still able to interact with CaM, whereas channels with mutated BDN, BDC2 and 
intact BDC1 no longer bind CaM (Goncalves and Stuhmer, 2010). It was also shown that the mutant 
CaM-EF12, i.e. a CaM in which the N-lobe EF hands 1 and 2 no not bind Ca2+, is able to inhibit the 
hEAG1 channel, albeit with reduced potency, while the C-lobe mutant CaM-EF34 (no Ca2+ binding at 
the C-lobe) does not inhibit the channel even at a concentration of 1 µM (Ziechner et al., 2006). 
Using isothermal calorimetry, we expand on the results of a previous study (Ziechner et al., 2006) and 
dissect the binding properties of CaM to the different sites in the EAG1 channel and to a large channel 
fragment that includes the CNBh domain, the BDC1 and BDC2 sites. Together with the X-ray crystal 
structure of the CaM-BDC2 complex and a functional and biochemical analysis of mutations in BDC2 
we provide new insights into the mechanism of CaM inhibition. 
Results 
Interaction of calmodulin with the BDC2 site 
The structural and biochemical properties of the PAS and CNBh domains from the mouse EAG1 
channel are well characterized (Adaixo et al., 2013; Fernandes et al., 2016; Haitin et al., 2013; 
Marques-Carvalho et al., 2012). As a consequence, we decided to perform the in-vitro 
characterization of the CaM binding properties to EAG1 using the mouse channel. For the functional 
analysis, however, we focused on the human EAG1 channel, where Cam inhibition has been well 
described (Marques-Carvalho et al., 2012; Sahoo et al., 2010; Schonherr et al., 2000; Ziechner et al., 
2006). Importantly, mouse and human EAG1 channels are very closely related; in the N-terminal 
region, which spans the PAS domain and BDN site, the two sequences differ only in 2 residues 
among 174, while in the C-terminal region, spanning the CNBh domain, BDC1 and BDC2 sites,  
sequences are 100% identical (Figure S1b and S1c).  
To characterize the interaction between calmodulin and the BDC2 site, we generated two maltose-
binding protein (MBP) fusions: BDC2S (S for short) where the channel fragment spans residues 733-
757, and BDC2L (L for long) where it spans residues 727-764 (Figure S1c). Both channel fragments 
are centered on the sequence originally defined by Schönherr et al. (Schonherr et al., 2000). 
Isothermal titration calorimetry (ITC) experiments with CaM, in the presence of saturating Ca2+, 
revealed higher affinity for BDC2L (KD ~70 nM) relative to the BDC2S (KD ~440 nM (Figure 1a, 1b, 
Table 1). The affinity increase is due to a more favorable enthalpy contribution (~-14 kcal /mol for 
BDC2L and ~-8 kcal/mol for BDC2S) suggesting that extra interactions are formed in the long 
fragment. We also noticed that removal of the MBP-tag from the BDC2S fusion by proteolytic 
cleavage was very inefficient in the presence of CaM, suggesting that bound CaM affects the action of 
the protease. As shown below, this probably results from an N-terminal shift of the CaM binding site 
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relative to the originally defined sequence. As a consequence of the difficulty with protease cleavage 
and of the lower affinity of BDC2S we focused our studies on BDC2L.  
We next assessed the contribution of individual CaM lobes to the interaction with BDC2. ITC 
experiments showed that the C-lobe of CaM binds almost as well as the full-length protein (KD ~ 110 
nM) and 20-fold more tightly than the N-lobe (KD ~2.2 μM) (Figure 1c, 1d, Table 1). A mutant CaM, 
which is not able to bind Ca2+ in the N-lobe (CaM-EF12), also showed tight binding (KD ~125 nM) 
(Figure S2a, Table 1), corroborating results obtained with the isolated C-lobe and demonstrating the 
importance of this lobe for CaM binding to BDC2. Titration experiments performed in the presence of 
EDTA (at 2 different temperatures: 15 ºC and 25 ºC), which ensured that calmodulin is in the Ca2+-
free apo state, showed very weak binding (KD >30 μM), and hence demonstrated that CaM binding to 
BDC2 is Ca2+ dependent (Figure S2b). 
Structure of Ca2+-calmodulin-BDC2 
The structure of BDC2L (after removing MBP) in complex with Ca2+-saturated calmodulin was 
determined at 2.85 Å resolution (Table 2). The molecular replacement procedure involved screening a 
collection of coordinates for the N- and C-lobes of CaM and the best search models were the 
coordinates of a Ca2+-bound C-lobe (from PDB 3OXQ) together with an apo-CaM N-lobe (from PDB 
1CFD).  The new structure shows the CaM molecule in an extended conformation, with the two lobes 
connected through a long helix and the BDC2 fragment sitting on the C-lobe (Figure 2a), confirming 
our ITC results. Despite the high concentrations of Ca2+ kept throughout complex formation and 
crystal growth, the N-lobe is in the apo form. The lack of bound Ca2+ is probably due to the lower ion 
affinity of the N-lobe (Yamniuk and Vogel, 2004) and the low pH of the crystallization condition (pH 
5), which may have resulted in protonation of chemical groups involved in ion coordination.  In 
contrast, the C-lobe adopts a bound-conformation with two calcium ions bound to the EF hands 3 and 
4. Probably as a consequence of the absence of bound Ca2+, some regions of the N-lobe EF-hands are 
ill-defined in the electron-density map and were not modeled. Using the PDBeFold server (Krissinel 
and Henrick, 2004) we found that the calmodulin structure that more closely resembles our structure 
is that of a trapped intermediate (PDB 1Y6W) in which both lobes contain Ca2+ but the N-lobe is 
locked in a apo-like conformation due to the introduction of a disulfide bridge (Grabarek, 2005).  
The channel fragment that could be structurally resolved comprises residues 727 to 743 (Figure 2b, 
S3); no density was observed for the C-terminal end of the BDC2L (residues 744 to 764), 
demonstrating that the interaction site for CaM is N-terminally shifted relative to the originally 
described BDC2 sequence. The BDC2 channel fragment adopts an intriguing conformation in the 
crystal structure (Figure 2b): the first 7 residues (727-732) are in an extended conformation and run 
along the side of the C-lobe between two crystallographically related molecules (Figure 2c), they are 
followed by an ~8-residue long helix that sits on the hydrophobic cleft of the C-lobe and is positioned 
at ~90º relative to the N-terminal residues. The interface formed by CaM and BDC2 amounts to 
531 Å2; some of the BDC2 residues involved in contacts with CaM (≤ 4Å from CaM) are: P728, L729 
and L731 in the N-terminal stretch, and P736, V737, R739, L740 and F741 C-terminal helix (Figure 
2b). The N-terminal residues A727, L729, I730 and L731 contact a neighboring CaM molecule 
(Figures 2b, 2c).  
There are two features in this structure that are worthwhile presenting in some detail because they 
appear to stabilize the complex and the BDC2 conformation.  First, at the center of the CaM-BDC2 
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interface there is group of apolar residues forming a “hydrophobic cluster” (Figure 2d) that includes 
A88, L112, M144 and M145 from CaM, V737, L740 and F741 from the C-terminal BDC2 helix), as 
well as L731 from the N-terminal BDC2 stretch. Second, the bending point or elbow of BDC2 
(residues 732-736) includes 3 prolines and adopts a compact structure which favors van der Waals 
interactions and hydrogen bonding between several residues (Figure 2e); for example, the main-chain 
carbonyl of P736 is within hydrogen bonding distance (≤ 3.5 Å) of main-chain amino groups of R738 
and R739, the same for P732 and H735 and for the side-chain of H735 and the main-chain amino 
group of V737.  
Biochemical and functional analysis of the Ca2+-calmodulin-BDC2 structure 
To better define the contribution of BDC2 residues for the stability of the CaM-BDC2 complex we 
analyzed the impact of mutations by ITC. Double alanine mutation of V737 and L740, two residues in 
the hydrophobic cluster (Figure 2d), has no impact on binding affinity (KD ~70 nM) (Figure S4a and 
3ar, Table 1)). However, a double serine mutation changed affinity by 230-fold (KD ~16 µM) (Figure 
S4b and 3a). Serine mutation at the neighboring F741, another residue in the cluster, changed affinity 
by ~28-fold (KD ~2 µM) (Figure S4c and 3a, Table 1).  
The only residue in the N-terminal extended region that participates in the hydrophobic cluster is 
L731 (Figure 2d); we mutated this residue together with L729, which is also in the N-terminus and 
interacts with CaM. Double mutation to alanine causes a ~5 kcal/mol change in binding enthalpy but 
had a only mild effect on affinity (KD ~ 300 nM) (Table 1, Figure S4d and 3a). Double serine 
mutations at the same positions had a stronger impact, causing a ~6 kcal/mol change in binding 
enthalpy and reducing affinity by 10-fold (KD ~700 nM) (Figure S4e and 3a, Table 1). Combination 
of L729A/L731A with R739A, a residue in the C-terminal helix of BDC2 that contacts CaM, resulted 
in an affinity change of 31-fold (KD ~2µM) (Figure S4f and 3a, Table 1). Overall, these results show 
that residues in the N-terminal extended stretch of BDC2 contribute for the stability of the complex 
but the interaction is dominated by residues on the C-terminal helix. 
We also assessed the functional impact of BDC2 mutations on CaM inhibition by mutating the full-
length human EAG1 (hEAG1) channel and recording ion currents from wild-type and mutant 
channels heterologously expressed in Xenopus oocytes, before and after exposure to ionomycin 
(Figure S5). Exposure to ionomycin raises the cytoplasmic Ca2+ levels in two distinct phases, a fast 
rising Ca2+ concentration peak that is thought to result from a release from intracellular stores 
followed by a longer-sustained lower Ca2+ concentration level when the cation is imported from the 
extracellular solution (Morgan and Jacob, 1994; Yao and Tsien, 1997; Yoshida and Plant, 1992). 
Unlike the peak, the Ca2+ concentration in the plateau region is dependent on the concentration of 
ionomycin. The hEAG1 response to ionomycin exposure was followed by repetitive depolarizing 
pulses to 40 mV and the normalized steady-state current level was plotted as a function of time 
(Figure 3b). For the wild-type channel the plot shows a peak in current inhibition by ~70% relative to 
values prior exposure to ionomycin, followed by a steady-state inhibition level of ~35% in the 400-
600 s time interval of ionomycin exposure. These two phases of inhibition appear to roughly follow 
the described evolution of cytoplasmic Ca2+ levels and, hence, we used the drop in channel current 
during the steady-state inhibition phase as an indicator of the functional Ca2+-related impact on BDC2 
channel mutants (Figure 3c). A report published while this work was under revision (Lorinczi et al., 
2016) interprets the time-dependent reduction in inhibition not as a response to a decrease in 
intracellular Ca2+ levels but as a recovery in channel activity; however, that work uses a different 
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experimental setup where oocytes are exposed to ionomycin and thapsigargin (an inhibitor of Ca2+-
ATPase). 
Serine mutations at V710 and L713 of hEAG1 (equivalent to V737 and L740 on the BDC2 helix – 
Figure 2b) had a strong effect on channel inhibition, with negligible current reduction during 
ionomycin exposure (Figures 3b and 3c).This drastic effect reflects the large impact of the equivalent 
mutations (V737S/L740S) in the in vitro stability of the CaM-BDC2 complex (compare green bars in 
Figures 3a and 3c – to facilitate comparison of equivalent mutants in the mouse and human EAG1 
channels data is shown with same-color bars in figures 3a and 3c). Also reflecting the biochemical 
results, alanine mutations at the same residues (dark-blue bars) had little effect on steady-state 
inhibition (~30% current decrease).  
Strikingly, although mutations L729A/L731A in the N-terminal extended stretch of BDC2 had a small 
effect on in vitro complex stability (Figure 3a, red bar), the equivalent mutation in hEAG1 
(L702A/L704A) caused a clear reduction of the channel’s Ca2+ sensitivity, less than 10% current 
decrease during steady-state inhibition (Figures 3b and 3c, red bar). Similarly, the double alanine 
mutant at D734 and H735, two residues in the elbow of BDC2 (Figure 2e), had no impact on the 
stability of CaM-BDC2 (KD~100 nM) (Table 1, Figure S4g and 3a, cyan bar) but a large functional 
impact on the hEAG1 channel (D707A/H708A), with steady-state inhibition of ~5% only (Figures 3b 
and 3c, cyan bar). P736A/V737A also had a very small impact on complex stability (KD ~120 nM) 
(Table 1, Figure S4h and 3a, magenta), but its equivalent in hEAG1 (P709A/V710A) had a clear 
functional effect (steady-state inhibition ~20%) (Figure 3b and 3c, magenta). Interestingly, although 
the analyzed mutants in the N-terminal stretch and elbow of BDC2 have little or no impact on binding 
affinity, they cause in a change in binding enthalpy of ~5 kcal/mol and higher (Table 1). Current-
voltage curves for mutant and wild-type hEAG1 channels showed that tested mutations did not greatly 
affect the voltage-dependent activation properties of the channels (Figure S5c).  
Overall, the functional analysis showed that mutants with an impact on channel inhibition occur at 
residues spread across the BDC2 sequence: in the C-terminal helix, the N-terminal extended stretch, 
and in the elbow created by the bending of BDC2. This is very different from the distribution of 
mutants with an impact in the in-vitro stability of the CaM-BDC2 complex, which is focused in the C-
terminal helix. 
Calmodulin interaction with the BDN and BDC1 sites 
To analyze the interaction between CaM and BDN we generated two MBP fusions, BDNS (residues 
145-168) and BDNL (residues 138-174) (Figure S1b). ITC experiments with Ca2+-saturated CaM 
showed that the affinity for BDNS is 10-fold lower (KD ~180 nM) than for BDNL
 (KD ~18 nM) 
(Figure 4a and 4b, Table 3). Unlike for BDC2, titrations with the isolated CaM lobes showed lower 
affinity for both lobes (N-lobe: KD ~4.5 μM, C-lobe: KD ~1.4 μM) (Figure 4c and 4d, Table 3), 
indicating that CaM interaction with BDN involves both lobes.  
Cell-based FRET experiments have suggested that CaM binds to the EAG1 channel in the absence of 
Ca2+ and that this interaction occurs through BDN (Goncalves and Stuhmer, 2010). Titrations in the 
presence of EDTA at 15 and 25 ºC showed no detectable binding of apo-CaM to BDNL (Figure S6a). 
In addition, mutant CaM-EF12 binds to BDN with low affinity (KD ~1.4 μM, Figure S6b). Overall 
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this shows that the tight interaction with BDN is Ca2-dependent and that any potential apo-CaM 
interaction with the EAG1 channel occurs at a yet undiscovered site.  
Due to the close proximity between BDN and the PAS domain (Figure S1b) we wondered if this 
domain influences the interaction between CaM and BDN. We used two constructs that span the 
globular region of the PAS domain and the BDN binding site (Figure S1b); one construct includes 
most of the PAS-Cap region, a stretch of N-terminal amino acids that have a role in channel function 
(Cap-PAS-BDN: residues 3 to 174), while the other does not (PAS-BDN: residues 28 to 174). We 
found that CaM binds to both constructs with a KD of ~100 nM (Figure S6c, S6d and Table 3), 
demonstrating that the PAS domain has only a slight effect on the interaction of CaM with BDN and 
that the PAS-Cap domains does not play a significant role in this interaction. 
To analyze the interaction between CaM and BDC1 we generated a channel fragment (CNBhD-
BDC1) that spans residues 552 to 724 and includes the CNBh domain plus the immediately adjacent 
BDC1 site (Figure S1c). Previously, using a fluorescence binding assay, we showed that CaM 
interacts weakly with BDC1 (Marques-Carvalho et al., 2012). We repeated this analysis with ITC and 
obtained a KD ~7 μM, confirming the previous finding (Figure S7). In addition, the binding reaction is 
endothermic and therefore entropically driven, showing that the interaction of CaM with BDC1 is 
very different from the interactions with BDN or BDC2. 
This conclusion led us to analyze in more detail the molecular neighborhood of BDC1. The crystal 
structure of the cytoplasmic assembly formed by the PAS domain and the CNBh domain shows that 
the BDC1 site residues are involved in the interaction between the two domains (Figure 5a). We 
wondered if the mutations in BDC1 that affect the CaM affinity and abolish CaM-mediated channel 
inhibition could also alter the stability of the PAS-CNBh domain complex. We tested this idea using a 
fluorescence anisotropy assay established to measure the stability of the PAS-CNBh domain complex 
in vitro (Haitin et al., 2013). Titration with wild-type CNBh domain resulted in an increase in 
fluorescence anisotropy of fluorescein-labeled PAS domain, which is well fitted by a binding 
isotherm with a KD of 17.5 ± 6.4 μM (Figure 5b). In contrast, titration with CNBh domains that 
include BDC1 mutations abolishing CaM inhibition in the channel and/or reducing BDC1 affinity 
(R702N/R704N /R708N/K709N and I705A/V706A/F707A) had no effect on fluorescence anisotropy 
of PAS, showing that in vitro the PAS-CNBh domain complex is severely destabilized. This result 
therefore gives rise to an alternative explanation for the effect of the BDC1 mutations on CaM 
inhibition: mutations in BDC1 probably destabilize the PAS-CNBh domain complex in the channel, 
altering the underlying mechanism of inhibition. This suggests that the integrity of the PAS-CNBh 
interaction is important for the mechanism of CaM-mediated EAG1 channel inhibition and supports a 
recent electrophysiological analysis of hEAG1 inhibition by CaM (Lorinczi et al., 2016). 
CaM interaction with a large C-terminal channel fragment 
The proximity between BDC1 and BDC2, the observation that CaM binds to BDC2 through the C-
lobe, and the previous suggestion that it binds to BDC1 through the N-lobe (Marques-Carvalho et al., 
2012) raised the possibility that one CaM molecule can bridge the two sites. With this in mind we 
analyzed the interaction of CaM with a channel fragment that spans the CNBh domain, BDC1 and 
BDC2 (CNBhD-BDC1-BDC2, residues 552 to 764 -Figure S1c). Titration with CaM showed an 
isotherm with two steps and different slopes (Figure 6a). This isotherm was not satisfactorily fitted 
using a model with a single site (or with a set of equal sites), ruling out the idea that CaM bridges 
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BDC2 and BDC1. Instead, we considered that CaM binding occurs separately at BDC1 and BDC2. 
Fitting the data with a model that includes two different and independent binding sites for CaM 
provided a satisfactory fit with potential interactions displaying KD values of 47 nM and 5 nM (Figure 
6a). However, the N values of both interactions (an indication of the interaction stoichiometry) were 
~0.4, which is unexpected for a complex formed by two CaM molecules binding at different sites. 
To dissect the interaction we first analyzed the binding of isolated CaM lobes and of mutant CaM-
EF12 to CNBhD-BDC1-BDC2 (Figures 6b, 6c and 6d). These titrations appeared to display a single 
transition with a stoichiometry close to 1 and a KD of 1.3 μM for the N-lobe, 75 nM for the C-lobe 
and 39 nM for CaM-EF12 (Table 3), indicating that the two-step isotherm depends on having a full-
length CaM, where both lobes contain Ca2+ and are involved in binding. Second, we generated 
channel fragments that either introduce BDC1 mutations previously shown to decrease CaM affinity 
(R702N/R704N /R708N/K709N) (Ziechner et al., 2006) or sequentially remove the CNBh domain 
(BDC1-BDC2, residues 696-764) and the BDC1 site (BDC1/BDC2 linker-BDC2, residues 712-764) 
(Figure S1c). Isotherms of CaM titrations into these fragments clearly show the presence of two steps, 
demonstrating that neither the CNBh domain nor the BDC1 site is involved with this property (Figure 
6e, 6f and 6g).  
As a consequence of this analysis we considered a sequential binding model where CNBhD-BDC1-
BDC2 binds to two different sites in CaM (the N- and C-lobes). This model (implemented in the 
AFFINImeter server) includes the parameter (rM) that accounts for deviations in the concentration of 
CNBhD-BDC1-BDC2. The final value for rM was nearly 1, indicating that the nominal concentration 
and stoichiometry of CNBhD-BDC1-BDC2 were correct. This supports the idea that CNBhD-BDC1-
BDC2 has a single region for interaction with CaM. If it had two different sites, for example, one for 
the C-lobe and another for the N-lobe, we would have obtained a value close to 2 for rM (indicating 
two binding sites).  
We refined this model further and imposed that the N- and C-lobes interact independently with the 
same or overlapping channel regions (Figure 7a), allowing us to extract site-specific parameters (KD 
~1.3 μM, ΔH ~ -4 kcal/mol and KD ~7 nM, ΔH ~ -14 kcal/mol) (Figure 7b and Table 3). A species 
distribution plot showed that at the beginning of the titration a fraction of the CaM molecules interact 
through the N-lobe while others interact through the C-lobe. As CNBhD-BDC1-BDC2 is depleted, 
the high-affinity C-lobe out-competes the N-lobe and by the end all CaM molecules are bound 
through the C-lobe.  
We also performed a competition experiment where C-lobe was titrated into CNBhD-BDC1-BDC2 
premixed with a saturating concentration of N-lobe (Figure 7c). This titration shows a single 
transition, which was fitted with the single-site model implemented in Origin, resulting in a KD ~300 
nM and ΔH ~-6 kcal/mol. The affinity drop and the change in enthalpy relative to the titration of C-
lobe in the absence of N-lobe show that both lobes compete for the same site in CNBhD-BDC1-
BDC2. Using a competitive model implemented in AFFINImeter, which takes into consideration the 
enthalpy and KD values determined previously for the N-lobe, we obtained KD ~11 nM and ΔH ~-14 
kcal/mol for the C-lobe (Figure 7c and Table 3). These values are similar to the ones obtained above 
for the high-affinity interaction in the two-site receptor model, supporting the model of a single site in 
CNBhD-BDC1-BDC2 with which the N- and C-lobes interact independently. 
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In addition, we performed an analysis of the CaM-(CNBhD-BDC1-BDC2) complex by native mass 
spectrometry (Figure S8). This revealed the presence of several forms of the complex in solution, 
including a 1:1 and 2:1 (CaM:channel fragment) complexes. Considering the measured affinities, the 
1:1 form most likely corresponds to a complex where one CaM molecule is bound to a channel 
fragment at BDC2.The 2:1 complex probably corresponds to two CaM molecules bound to a channel 
fragment, one at BDC2 and another at BDC1.  Binding of CaM to BDC1 was not apparent in our ITC 
analysis titration of CNBhD-BDC1-BDC2. This distinction is easily resolved if one considers the 
differences in the enthalpies of binding for CaM to BDC1 and BDC2. CaM binding to BDC1 has a 
low heat of enthalpy (∆H ~2 kcal/mol) relative to full-length CaM, or C-lobe CaM (-14 and -10 
kcal/mol, respectively; Table 1). This difference associated with a lower affinity (Table 1) most likely 
makes the heat contribution of the CaM-BDC1 interaction undetectable during the ITC titration of 
CNBhD-BDC1-BDC2. 
A 2:2 form was also identified in the spectrum; it differs from the 1:1 form through the mass of its 
odd-charged species and in our spectrum is identified through the presence of a single peak that is not 
explained by other combinations of molecular masses (Figure S8). As shown above for BDC2 and 
proposed previously for BDC1 (Marques-Carvalho et al., 2012), binding of CaM to these sites occurs 
preferentially through a single lobe (N-lobe for BDC1 and C-lobe for BDC2), leaving therefore free-
lobes to interact with sites in another CNBhD-BDC1-BDC2 molecule so that two CaM molecules can 
bridge two channel fragments, possibly in a head-to-tail arrangement.  
Discussion 
In this study we have dissected the binding properties of the three CaM binding sites in the EAG1 
channel (BDC1, BDN and BDC2). In particular, we confirmed that the affinity of CaM for BDC1 is 
much lower (in the micromolar range) than for the other two sites (in the low nanomolar range).  This 
weak interaction does not rule out a role of BDC1 in the mechanism of channel inhibition by CaM. 
However, we have found that mutations that affected CaM inhibition and that supported the 
functional importance of BDC1 also cause a destabilization of the complex between the PAS and 
CNBh domains. It is therefore possible that the previously described impact of these mutations on 
CaM inhibition does not reflect changes in the interaction of CaM with BDC1 but instead is the result 
of structural changes in the channel and consequent alteration of the machinery of CaM inhibition. 
The implication of this result is that a role of BDC1 in the mechanism of EAG1 inhibition has not 
been established.   
Our results also show that the low nanomolar affinity (KD ~18 nM) between CaM and BDN is 
dependent on the presence of the two CaM lobes, indicating  that in vitro CaM probably adopts a 
canonical conformation with both lobes wrapped around the target region. In addition, although the 
PAS domain is positioned very close to BDN, the globular domain does not greatly affect the affinity 
of CaM towards BDN. 
Our analysis of CaM binding to a large channel fragment (CNBhD-BDC1-BDC2) revealed that the 
CaM interaction with BDC2 is complex and involves competing interactions between the N- and C-
lobe. Crucially we showed that the interaction between the C-lobe and BDC2 is very tight (KD ~7 
nM). The crystal structure of the CaM–BDC2 complex confirms this finding and shows an unusual 
conformation of the channel fragment, with the C-terminal helix of BDC2 lying in the C-lobe 
hydrophobic cleft of CaM and the N-terminal half adopting an extended conformation that is 
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perpendicular to the helix.  Interestingly, the conformation of BDC2 roughly resembles the one found 
in the structure of CaM bound to a fragment of the Orai1 channel (Liu et al., 2012). In the Ora1 
structure the N-terminal half of the channel fragment is also in an extended conformation and the C-
terminal half forms a helix. Just like in our structure, the two sections of the channel fragment are 
positioned at ~90º of each other and the helix lies on the cleft of the C-lobe of CaM. However, the 
fragments are in different orientations in the two structures, almost as mirror images of each other. An 
important point to consider about the CaM-BDC2 structure is whether the BDC2 conformation is a 
crystal artifact and  bending of the channel fragment is the result of crystal lattice contacts between 
the N-terminal stretch and a neighboring CaM molecule. This issue is discussed in detail further 
down. 
Based on data presented here and on previously published results we considered two models for the 
mechanism of CaM action: a model where CaM induces a global conformational change in the 
cytoplasmic regions of the channel and another where the effect of CaM is local. In both models the 
very tight interaction between the C-lobe of CaM and BDC2 is central for the mechanism of 
inhibition. The global conformation model is based on the fact that when CaM binds to BDC2 it 
leaves the N-lobe free to interact with other channel regions. It is therefore plausible to consider that, 
in the full-length channel, CaM binds to BDC2 through the C-lobe, while the N-lobe either interacts 
with BDN, bridging the N- and C-termini of the channel, or with another BDC2 site, bridging 
subunits. Our ITC and mass spectrometry analyses of the CNBh-BDC1-BDC2 channel fragment seem 
to rule out CaM-bridging of BDC2 and BDC1 and the 2:2 complex species identified by native mass 
spectrometry suggests that bridging of different subunits is possible. The affinity of the N-lobe for 
either BDN or BDC2 sites is low (KD ~2-4 µM), however, a simple calculation for 4 BDN sites in a 
hemisphere volume with a radius of 200 Å (as a comparison the thickness of a lipid bilayer is ~50 Å) 
reveals local concentration values that are hundreds of times above KD. Altogether this suggests a 
model where CaM bridges distant channel regions and induces a global conformational change that 
results in channel inhibition. Similar models have been proposed for the mechanisms of how voltage-
gated Ca2+ channels (Ben Johny et al., 2013) or voltage-gated Na+ channels (Gabelli et al., 2014; 
Sarhan et al., 2012) are modulated by CaM. 
The local conformation model emerges out of the previously published observation (Ziechner et al., 
2006) that the mutant CaM-EF12 (where the N-lobe does not bind Ca2+) is able to inhibit the hEAG1 
channel, although with reduced potency: wild-type CaM at 270 nM reduced channel current to ~9%, 
while CaM-EF12 at a 4x higher concentration reduced the current to ~30%. In contrast, CaM-EF34 
mutant (no Ca2+ binding at the C-lobe) did not inhibit the channel even at 1 µM. This result suggests 
that the interactions through the N-lobe are not required for inhibition and, therefore, that the 
mechanism of inhibition is not dependent on CaM bridging.  This leads us to consider a model where 
inhibition results from a local conformational change induced by the C-lobe.  
The bent conformation of the BDC2 channel fragment present in our CaM–BDC2 structure (Figure 2a 
and 2b) seems to provide evidence to support this model. However, the observation that the N-
terminal stretch of BDC2 lies between crystallographically related CaM molecules (Figure 2c) 
together with the small impact in binding affinity of mutations in this section and in the elbow of 
BDC2 could be an indication that the bent conformation is a crystallographic artifact and that the N-
terminal stretch is not relevant for the inhibition mechanism. Strikingly, we have found that mutations 
in the N-terminal stretch and elbow have a large functional effect. This is particularly evident in the 
alanine mutations at the two leucine residues in the N-terminal stretch (L702 and L704 in hEAG1 - 
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red bar in Figure 3c) or at the aspartate and histidine residues positioned in the elbow of BDC2 (D707 
and H708 in hEAG1 – cyan bar in Figure 3c). Moreover, a closer inspection of the thermodynamic 
parameters extracted from the ITC experiments reveals that these mutations, although not changing 
affinity, cause a clear change in binding enthalpy (by at least 5 kcal/mol) indicating that binding 
interactions have been altered by the mutations. Although we cannot rule out the possibility that the 
bent conformation of BDC2 is the result of contacts with the crystal lattice, the changes in binding 
enthalpy and functional impact associated with the mutants in the N-terminal section of BDC2 are 
consistent with the involvement of these residues in the interactions observed in the hydrophobic 
cluster (Figure 2d) and elbow (Figure 2e), which seem to stabilize the bent conformation. 
The functional and biochemical mutagenesis results can be explained if the interaction between the C-
lobe and BDC2 is dominated by the C-terminal BDC2 helix sitting on the cleft of the lobe, while the 
inhibitory effect requires the stabilization of the bent conformation in BDC2. Thus, in the local 
conformation model we propose that both the interaction with BDC2 and the stabilization of the bent 
conformation play a role in the inhibitory mechanism. In this model the “free” N-lobe of CaM still 
interacts with other regions of the channel, but these serve to further stabilize the local structural 
change induced by CaM increasing the potency of its inhibitory effect.  
Our structural, biochemical and functional analysis of the CaM binding sites within the EAG1 
channel suggests that the molecular change induced by CaM and underlying channel inhibition occurs 
locally. This appears to be very different from the mechanisms proposed for other tetrameric cation 
channels (Na+ and Ca2+ channels)  (Ben Johny et al., 2013; Gabelli et al., 2014; Sarhan et al., 2012) 
where CaM bridges sites in different regions of the channel giving rise to a global conformational 
change. It is interesting to notice, however, that in CaV1.3 the isolated CaM lobes also have an effect 
on channel function (Ben Johny et al., 2013). This means that bridging is not an absolute requirement 
for the mechanism of CaM in these channels and that local conformational changes play a role in 
these processes just like in EAG1 potassium channels. We still do not know how the CaM-induced 
change is reflected in channel inhibition and further studies will be necessary for a full understanding 
of the molecular mechanisms coupling CaM binding to conformational changes involved in channel 
opening.  
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Experimental procedures 
Expression and purification of protein constructs 
Calmodulin binding sequences BDN and BDC2 from mEAG1 (accession codes NP_034730.1 and 
GI:6754422) were cloned into multiple cloning site 1 (MCS1) of modified pRSFDuet-1 (Novagen) 
which includes an N-terminal His6-tag, maltose binding protein (MBP) and a TEV protease 
recognition sequence (HMT) at MCS1. Expression and purification of MBP fusions, calmodulin and 
channel fragments is described in SI and (Marques-Carvalho et al., 2012). CNBhD-BDC1 was 
prepared as described in (Marques-Carvalho et al., 2012).  
Isothermal titration calorimetry 
Titration components were dialyzed overnight against 50 mM Hepes pH 7.5, 150 mM NaCl, 5 mM 
CaCl2, 1 mM TCEP (when necessary CaCl2 was replaced by 5 mM EDTA) in the same beaker to 
avoid buffer mismatch. CaM concentration was determined by 277 nm absorbance (ε277nm=3029 M
-1 
cm-1) (Strasburg et al., 1988). Channel fragment concentration was determined by 280 nm absorbance 
using extinction coefficients calculated with ExPASy tool Protparam. CaM was degassed for 5 min 
before experiment. Titrations were performed at 25 ºC using a VP-ITC instrument (MicroCal), with a 
first injection of 2 µL, followed by 28x10 µL injections. Data were analyzed with MicroCal-Origin 7 
or AFFINImeter. The first injection was ignored and correction for the heat of dilution was made by 
subtracting the average of the last four injection areas from all injection points. 
Purification calmodulin-BDC2 complex for crystallization 
The BDC2 MBP-fusion was co-expressed with CaM (cloned into MCS2 of pRSFDuet-1, without 
affinity tag). Preparation of the calmodulin-BDC2 complex is as for BDC2, except that buffers 
included 5 mM CaCl2. Details in SI.  
Crystallization, data collection, and refinement 
Crystals were grown at 20 °C by sitting-drop and mixing a 1:1 (v/v) ratio of protein mixture with 
reservoir solution containing 0.2 M di-ammonium citrate pH 5, 20% PEG 3350. Data were collected 
at Proxima 2A beamline (Soleil Synchrotron) and were integrated and scaled using XDS (Kabsch, 
2010) and Aimless (Evans and Murshudov, 2013) - CCP4 program suite (Winn et al., 2011). Structure 
was solved by molecular replacement with Phaser (McCoy et al., 2007) using ensembles of 
calmodulin N- and C-lobes as search models (PDB codes: 1CFD, 1CLL, 2BE6, 3DVM, 3OXQ chain 
A, 3OXQ chain B, 4DJC and 4GOW). Model was refined in PHENIX (Adams et al., 2010) with TLS 
(Painter and Merritt, 2006), built in Coot (Emsley and Cowtan, 2004) and figures created in PyMOL 
(DeLano, 2002). 
Fluorescence anisotropy 
PAS domain (mEAG1 1-137) was cloned in a pET15b vector. Expression and purification protocol is 
described in SI. Fluorescein labeling of PAS domain cysteines and binding assay are as described in 
SI and (Taraska et al., 2009; Haitin et al., 2013).  
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Electrophysiology  
Mutagenesis and mRNA synthesis were performed as in (Ziechner et al., 2006). For hEAG1 channel 
expression, stage V oocytes from X. laevis were injected with 50 nl of diluted mRNA. Ionic currents 
were recorded at 20-23 °C in two-electrode voltage clamp, using a Turbo-TEC 10CD amplifier (NPI 
electronic, Tamm, Germany) controlled by the PatchMaster software (HEKA Elektronik, Lambrecht, 
Germany); P/n leak correction was applied. Bath solution contained (in mM): 115 NaCl, 2.5 KCl, 1.8 
CaCl2, 10 HEPES; pH 7.2 (NaOH). Ca2+ sensitivity was assessed using the ionophore ionomycin, 
applied during repetitive test pulses (from -120 mV to 40 mV; 400 ms) with 10 sec intervals. Control 
wash with bath solution (2 ml) was performed after 10 pulses. Ionomycin (1 µM in 2 ml bath 
solution) was added after 20th pulse and washed out after pulse 60. Current amplitudes in test pulses 
were normalized to last pulse before ionomycin application and mean current reduction was evaluated 
for steady-state inhibition. Data were analyzed with FitMaster software (HEKA Elektronik) and 
IgorPro (WaveMetrics, Lake Oswego, OR, USA). Groups of data were compared with a two-sided 
student’s t-test assuming unequal variances. 
Native mass spectrometry 
Protein samples were desalted by Micro gel filtration spin columns (7 kDa cut-off and with a bed 
volume of 75 µL- Zeba, Thermo Scientific) equilibrated with 100 mM ammonium acetate pH 7. 
Desalted samples were analyzed in native conditions by direct infusion in a 4-GHz MaXis ultra-high-
resolution Q-TOF mass spectrometer from Bruker Daltonics (Germany) equipped with electrospray 
ion source.  
Spectra were acquired in positive ion MS mode over a 1000–5500 m/z range with nebulizer gas 
pressure of 0.8 bars and spray voltage of –4 kV. Drying gas flow was 7 liter/min 
andtemperature120 °C. In source collision induced dissociation (isCID) parameter was adjusted at 
100 eV to preserve noncovalent interactions of protein complex. Acquisition rate was 1 Hz 
corresponding to spectra summations of 4081. External calibration was performed with the ESI-L 
Low Concentration Tuning Mix (Agilent Technologies). Mass spectra were processed using 
DataAnalysis 3.1 software (Bruker Daltonics). 
Accession numbers  
Atomic coordinates and structure factors of calmodulin-BDC2 complex structure are deposited in the 
PDB under accession code PDB: 5HIT.  
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Figure 1: Characterization of the interaction of CaM with BDC2. a) ITC titration of 60 µM CaM 
into 6 µM MBP-BDC2S. b) Titration of 60 µM CaM into 6 µM MBP-BDC2L. c) Titration of 180 µM 
N-lobe CaM into 19 µM MBP-BDC2L. d) Titration of 100 µM C-lobe CaM into 10 µM MBP-
BDC2L. Top graphs show heat power changes, bottom graphs show integrated heat values fitted with 
a model curve. Cartoons represent components in each titration with CaM lobes (N- and C-, as 
labeled) shown as circles, full-length CaM represented by linked circles, Ca2+ bound in lobes shown 
as closed dots, lobes without Ca2+ have no dots. Experiments performed in saturating Ca2+ 
concentrations (5 mM). 
 
Figure 2: Structure of calmodulin in complex with BDC2. a) Full view of Ca2+-CaM-BDC2 
structure with CaM in red cartoon and BDC2 in cyan. Calcium ions are represented by black spheres. 
b) Zoom over the C-lobe (shown as surface) and BDC2 channel fragment (in stick). c) View of the 
crystal lattice with neighboring CaM molecules in lilac.  d) View of residues in hydrophobic cluster. 
Only side-chains are shown, cyan for BDC2 and red for CaM. Van der Waals contacts (≤ 4 Å) shown 
as dashed lines. Ca2+ shown as spheres. e) View of residues in elbow of BDC2 with potential 
hydrogen bond network (donor and acceptor at ≤ 3.5 Å) shown as dashed lines. 
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Figure 3: Characterization of BDC2 mutants. a) Dissociation constant ratios for wild type CaM-
BDC2 complex relative to mutants. b) Time course of normalized current inhibition after elevation of 
intracellular Ca2+ by extracellular exposure to 1 µM ionomycin. Wild-type and mutant hEAG1 
channels were expressed in Xenopus oocytes and currents were recorded in two-electrode voltage 
clamp. Averaged currents during repetitive test pulses (40 mV) were normalized to current amplitudes 
before exposure to ionomycin. Numbers of independent experiments are in parentheses. c) 
Quantification of steady-state inhibition seen in b). Errors are SEM. Equivalent mutations are shown 
as bars of the same color in a) and c).  
 
 
 
 
Figure 4: Characterization of the interaction of calmodulin with BDN. a) ITC titration of 60 µM 
CaM into 6 µM MBP- BDNS. b) Titration of 60 µM CaM into 6 µM MBP-BDNL. c) Titration of 253 
µM N-lobe into 23 µM MBP-BDNL. d) Titration of 258 µM C-lobe into 23 µM MBP-BDNL. 
Organization of panels and symbols as in Figure 1. Experiments performed in saturating Ca2+ 
concentrations (5 mM). 
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Figure 5: BDC1 mutations affect interaction between PAS and CNBh domains. a) Interface of 
complex formed by mEAG1 PAS (cyan and grey) and CNBhD-BDC1 (blue and grey) (Haitin et al., 
2013). C terminus of CNBhD-BDC1 corresponds to either residue 717, 718 or 720 depending of 
which of the 4 complexes present in the crystal structure (PDB 4LLO) is analyzed. Intrinsic ligand 
residues in CNBh domain are shown; BDC1 region and residues in PAS domain that interact with 
BDC1 depicted in stick. b) Fluorescence anisotropy of fluorescein-labeled PAS domain titrated with 
wild-type CNBhD-BDC1 (squares) and with same protein mutated in the BDC1 region: 
R702N/R704N/R708N/K709N (circles) and I705A/V706A/F707A (crosses). 
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Figure 6: Characterization of the interaction of calmodulin with CNBhD-BDC1-BDC2. a) ITC 
titration of 187 µM CaM into 17 µM CNBhD-BDC1-BDC2, fitted with model considering two sets of 
independent sites on the channel fragment. b) Titration of 140 µM N-lobe into 14 µM CNBhD-
BDC1-BDC2. c) Titration of 100 µM C-lobe into 10 µM CNBhD-BDC1-BDC2. d) Titration of 100 
µM CaM-EF12 into 100 µM CNBhD-BDC1-BDC2. e) Titration of 60 µM CaM into 6 µM MBP-
BDC1-BDC2, fitted as in a). f) Titration of 70 µM CaM into 6 µM MBP-linkerBDC2, fitted as in a). 
g) Titration of 60 µM CaM into 6 µM CNBhD-BDC1-BDC2 BDC1 mutant 
R702N/R704N/R708N/K709N, fitted as in a). Arrows indicate steps in binding isotherms. 
Organization of panels and symbols as in Figure 1; mutated Ca2+-binding sites shown as small x, large 
X indicates mutations in BDC1. Experiments performed in saturating Ca2+ concentrations (5 mM). 
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Figure 7: Modeling of calmodulin binding to CNBh-BDC1-BDC2.  a) CaM independent-site 
binding model. k represents site-specific binding constants for each lobe (N- or C-). Cartoons as in 
Figure 1. b) Titration of 187 µM CaM into 17 µM CNBhD-BDC1-BDC2 (same data as in Figure 5a) 
fitted with model shown in a), together with respective species distribution plot. c) Titration of 100 
µM C-lobe into a mixture of 7 µM CNBhD-BDC1-BDC2 and 35 µM N-lobe and species distribution 
plot. All experiments performed in saturating Ca2+ concentrations (5 mM). 
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Supplemental Information:  
It includes eight supplemental figures. It also includes Supplemental Experimental Procedures and 
Supplemental references.   
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Figure S1, related to Figures 1, 4, 5 and 6: The EAG1 channel and its cytosolic regions. a) Cartoon 
representation of EAG1 channel subunit, with CaM binding sites and cytosolic globular domains 
shown. Amino acid sequence of b) N-terminal and c) C-terminal EAG1 channel cytosolic regions and 
limits of constructs used in this study.  
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Figure S2, related to Figure 1: Titrations of BDC2 with Ca2+-CaM EF12 mutant and with full-length 
CaM in the absence of Ca2+. a) ITC titration of 60 µM MBP-BDC2long into 6 µM Ca2+-CaM EF12 
mutant. b) Titration of 500 µM apo-CaM into 50 µM MBP-BDC2long in the presence of 5 mM EDTA 
and at 25 ºC. Top graphs show heat power changes during injections, while bottom parts show the 
integrated heat values fitted with a model curve. Cartoons represent the components in each titration 
with CaM lobes (N- and C-, as labeled) shown as circles, full-length CaM represented by linked 
circles, Ca2+ bound in lobes shown as closed dots (lobes without bound Ca2+ have no dots). 
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Figure S3, related to Figure 2: Stereo-view of the BDC2 channel fragment (shown as stick) bound to 
the C-lobe of CaM (red cartoon). 2Fobs-Fc map is shown as a mesh surrounding the BDC2.  
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Figure S4, related to Figure 3.Titrations of BDC2 mutants with Ca2+-CaM. Representative ITC 
titrations for each mutant; top graphs show heat power changes during injections, while bottom parts 
show the integrated heat values fitted with a model curve.  
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Figure S5, related to Figure 3: Endogenous current induced by ionomycin and current-voltage 
relationship of hEAG1 and BDC2 mutants. Representative current responses from two-electrode 
voltage clamp experiments measured in frog oocytes. Repetitive test pulses (300 ms) to +40 mV were 
applied every 10 s. The last current trace before treatment and the second trace in the presence of 1 
µM ionomycin are shown for a) hEAG1 and b) for a water-injected oocyte. The inset in a) shows the 
tail currents in larger magnification. c) Mean endogenous current amplitudes from ionomycin-treated 
control cells (n=5); errors are SD. d) Normalized steady-state currents plotted versus depolarization 
voltages for wild type and BDC2 mutants. Depolarizing test pulses (2 s) ranged from -100 mV to +50 
mV in steps of 10 mV and The numbers of experiments are given in parentheses; errors are SEM.  
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Figure S6, related to Figure 4: BDN interactions. a) ITC titration of 500 µM apo-CaM into 50 µM 
MBP-BDNlong, in the presence of 5 mM EDTA. b) ITC titration of 135 µM Ca2+-CaM EF12 mutant 
into 13 µM MBP-BDNlong. c) ITC titration of 60 µM Ca2+-CaM into 6 µM Cap-PAS-BDN. d) ITC 
titration of 60 µM Ca2+-CaM into 6 µM PAS-BDN. Top graphs show heat power changes during 
injections, while bottom parts show the integrated heat values fitted with a model curve. Cartoons 
represent the components in each titration with CaM lobes (N- and C-, as labeled) shown as circles, 
full-length CaM represented by linked circles, Ca2+ bound in lobes shown as closed dots (lobes 
without bound Ca2+ have no dots) and mutated Ca2+-binding sites shown as x. 
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Figure S7, related to Figure 5: ITC titration of 500 µM Ca2+-CaM into 50 µM CNBhD-BDC1. Top 
graph shows heat power changes during injections, while bottom part shows the integrated heat values 
fitted with a model curve. Cartoon represents the components in the titration with full-length CaM 
represented by two linked circles (N- and C-lobes, as indicated) with bound Ca2+ (closed dots). 
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Figure S8, related to Figures 6: Native UHR-QTOF mass spectrum of CaM-(CNBhD-BDC1-BDC2) 
complexes. The mEAG CNBhD-BDC1-BDC2 domain in complex with calmodulin in a 1:1 ratio 
containing 1mM Ca2+ were desalted into a solution of ammonium acetate, 100 mM, pH 7.0 and 
analyzed by ultra-high resolution QTOF MS using direct infusion. The analyzed sample contains Ca2+ 
associated with the protein. Assigned identity of species present in the spectra is indicated. The 2:2 
CaM:CNBhD-BDC1-BDC2 complex is distinguishable from the 1:1 complex through its odd-charged 
species and explains a peak, marked with blue “21+”, which is not accounted by the other complexes. 
Supplemental Experimental Procedures: 
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Purification of MBP fusions 
Pellets of cells expressing MBP fusions were resuspended in buffer A (50 mM HEPES pH 7.5, 250 
mM KCl) supplemented with protease inhibitors. Cell lysis was performed in a cooled cell cracker 
(Emulsiflex-C5, Avestin) and the lysate was centrifuged at 32 800xg for 45 min at 4 ºC to remove cell 
debris. The supernatant was loaded into a His-select Nickel Affinity Gel (Sigma) column pre-
equilibrated with buffer A. Beads were first washed with buffer A followed by buffer A with extra 
KCl (500 mM). Most of the fusion protein was eluted from the resin with buffer A containing 20 mM 
imidazole. The remaining His-tagged protein was eluted with buffer A containing 250 mM imidazole. 
The eluted protein was pooled and dialyzed against buffer B (50 mM HEPES pH 7.5, 150 mM NaCl, 
5 mM CaCl2,1 mM TCEP) and loaded into a S200 size-exclusion chromatography column (GE 
Healthcare), pre-equilibrated with buffer B. 
Purification of large EAG1 channel fragments 
Several constructs (cap-PAS-BDN, PAS-BDN and CNBhD-BDC1-BDC2) suffer proteolysis during 
expression in bacteria. To overcome this problem, these were cloned into MCS1 of vector pRSFDuet-
1 with an N-terminal His6-tag and CaM was cloned into MCS2 of the same vector without any 
affinity tag. Co-expression with CaM shields the mEAG1 the protein fragments from proteases. 
Expression and purification was performed as described in (Marques-Carvalho et al., 2012) except 
that the buffering agent was 50 mM HEPES pH 7.5. Despite the lack of calcium in the lysis and wash 
buffers, CaM still came attached to the eluted protein. To disrupt the complex, the eluted protein was 
dialyzed against buffer C (50 mM HEPES pH 7.5, 150 mM NaCl, 1 mM EDTA, 5 mM DTT). The 
dialyzed protein was loaded into a 5 mL Hitrap Q HP (GE Healthcare) equilibrated with buffer D (50 
mM HEPES pH 7.5, 150 mM NaCl, 5 mM DTT). The mEAG1 fragment-enriched flow-through was 
collected, and CaM was eluted from the beads with a NaCl gradient. The channel fragment was 
further purified in a S200 size-exclusion chromatography column, pre-equilibrated with buffer B. 
Expression and purification of CaM lobes and mutants 
CaM lobes and the CaM-EF12 mutant (mutations D21A/D57A) were cloned as His6-tagged MBP 
fusions and purified as described for the other MBP fusions. Briefly, cleared bacterial lysate was 
loaded into a His-select nickel affinity column and eluted with buffer A containing 20 and 250 mM 
imidazole. TEV protease was added to the eluted protein to cleave MBP-tag from the CaM lobes and 
dialyzed overnight against buffer B. After cleavage, the protein solution was further purified using 
nickel beads to bind the His6-tagged TEV protease and MBP. Flow-through containing the lobe was 
kept. The solution was loaded into an affinity column MBPtrap (GE Healthcare) to remove any MBP 
contaminants. CaM lobes were further purified in a S200 size-exclusion chromatography column 
equilibrated in buffer B. 
Purification of CaM-BDC2 for crystallization 
Purification was as for BDC2 except that buffers included 5mM CaCl2. After elution from Ni-beads, 
MBP tag was cleaved off overnight with TEV protease. A second step of Ni-beads bound most MBP 
and TEV protease. Flow-through containing the CaM-peptide complex was loaded into an affinity 
column MBPtrap to remove remaining MBP. Complex present in flow-through was further purified in 
a S200 size-exclusion chromatography column equilibrated with buffer E (20 mM HEPES pH 7.5, 
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150 mM NaCl, 1 mM CaCl2, 1 mM TCEP). Protein was concentrated to 780 µM (~16 mg/mL) before 
setting crystallization drops. 
Expression and purification of PAS domain (mEAG1 1-137) for fluorescence spectroscopy.  
Briefly, PAS domain was expressed at 37 ºC in Escherichia coli BL21 (DE3) in Luria broth medium 
supplemented with kanamycin (50 mg/L) until the 600 nm optical density reached 0.6–0.8. At this 
point, cultures were placed on ice for 30 min. Ethanol and IPTG were added to a final concentration 
of 2%(v/v) and 0.5 mM, respectively, for overnight induction at 18 ºC. The pelleted culture was 
resuspended in buffer F (50 mM Tris-HCl pH 8, 150 mM NaCl, 5 mM imidazole) supplemented with 
protease inhibitors. Cell lysis was performed in a cooled cell cracker (Emulsiflex-C5, Avestin) and the 
lysate was centrifuged at 32 800xg for 45 min at 4 ºC to remove cell debris. The supernatant was 
loaded into Ni-beads pre-equilibrated with buffer F and washed with buffer F until the 280 nm optical 
density stabilized. The beads were washed with buffer F + 300 mM NaCl and buffer F containing 20 
mM imidazole. Protein was eluted with buffer F containing 150 mM imidazole. To remove imidazole, 
the eluted protein was dialyzed against buffer G (20 mM Tris-HCl pH 8.0, 150 mM NaCl and 5 mM 
DTT) and loaded into a S200 size-exclusion chromatography column (GE Healthcare), pre-
equilibrated with the same buffer. 
Labeling of PAS cysteines and Fluorescence assay to analyze the PAS-CNBh interaction 
PAS was incubated with 1 mM TCEP for 1 h at 4 °C to reduce cysteine residues. It was passed 
through a desalting column equilibrated with buffer H (20 mM Tris HCl pH 8.0, 150 mM NaCl) and 
incubated with fluorescein-5-maleimide (Molecular Probes) at molar ratios 1:5 and 1:10 for 1h at 
room temperature, protected from light. After 1 h the reaction was stopped with 5 mM DTT and 
dialyzed against buffer G using a 3.5 kDa cutoff dialysis membrane. 
For the fluorescence assay fluorescently labeled PAS at 100 nM was incubated with different 
concentrations of CNB-homology domain in the dialysis buffer G for at least 20 min. Fluorescence 
anisotropy measurements were performed at 25 °C in a Horiba Fluoromax-4 spectrofluorimeter using 
an excitation wavelength of 492 nm and emission of 514 nm, with slit widths of 1 or 2 nm. To 
estimate binding affinity, plots of the anisotropy versus total CNB-homology domain concentration 
were fit with: 
 
  
 
in which Rt and Lt are total receptor and total ligand concentrations, respectively, KD is the ligand-
binding affinity, and α and β are a scaling factor and an offset factor, respectively. 
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